IMA Market Cap History — ImageneBio Capitalization Over Time

As of 4/30/2026 ImageneBio has a market cap of 67.90 million. Investors often follow the IMA market cap history to compare the size of the company over time.

This page shows IMA market capitalization trends over time, with 4 market cap datapoints presented, dating back to 6/30/2025.

Quick links: Market Cap History Table  |  Market Cap History Chart  |  About ImageneBio
IMA Market Cap History



Below is a table of the IMA market cap history going back to 6/30/2025:

Date IMA Market Cap
6/30/202564.67M
11/3/202593.93M
3/2/202667.87M
4/30/202667.90M

Also see: IMA Shares Outstanding History
and IMA YTD Return
IMA Historical Market Cap:
+6.01% CAGR
IMA Historical Market Cap: +6.01% CAGR

Mouse over chart for data details
6/30/202511/3/20253/2/20264/30/2026
Ikena Oncology, Inc. is a targeted oncology company. Co. is focused on developing differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Co.'s lead targeted oncology program, IK-930, is a transcriptional enhanced associate domain 1 (TEAD1) selective Hippo pathway inhibitor, a known tumor suppressor pathway that also drives resistance to multiple targeted therapies. Co.'s second clinical-stage program targets the RAS signaling pathway with IK-595, a novel MEK-RAF molecular glue. It has IK-175 aryl hydrocarbon receptor (AHR) antagonist program that completed Phase 1 clinical trial. We show 4 historical shares outstanding datapoints in our IMA shares outstanding history coverage, used to compute IMA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing IMA market cap history over the course of time is important for investors interested in comparing IMA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of IMA versus a peer is one thing; comparing IMA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like IMA can fluctuate over the course of history. With this page we aim to empower investors researching IMA by allowing them to research the IMA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree IMA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap
ImageneBio (IMA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

IMAC Market Cap History
IMDX Market Cap History
IMDZ Market Cap History
IMGN Market Cap History
IMGO Market Cap History
IMMU Market Cap History
IMMX Market Cap History
IMMY Market Cap History
IMNM Market Cap History
IMNN Market Cap History
More Healthcare companies »
 

IMA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.